LSV Asset Management purchased a new stake in Ardent Health, Inc. (NYSE:ARDT – Free Report) during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm purchased 109,100 shares of the company’s stock, valued at approximately $963,000.
A number of other institutional investors also recently modified their holdings of the company. Zurcher Kantonalbank Zurich Cantonalbank bought a new position in Ardent Health during the third quarter worth $61,000. New York State Common Retirement Fund increased its position in Ardent Health by 121.4% during the second quarter. New York State Common Retirement Fund now owns 6,200 shares of the company’s stock worth $85,000 after acquiring an additional 3,400 shares during the period. Zurcher Kantonalbank Zurich Cantonalbank increased its position in Ardent Health by 126.1% during the fourth quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 10,400 shares of the company’s stock worth $92,000 after acquiring an additional 5,800 shares during the period. Squarepoint Ops LLC bought a new position in Ardent Health during the third quarter worth $145,000. Finally, Marshall Wace LLP bought a new position in Ardent Health during the second quarter worth $147,000.
Analyst Upgrades and Downgrades
A number of equities analysts recently issued reports on ARDT shares. Royal Bank Of Canada dropped their target price on shares of Ardent Health from $14.00 to $13.00 and set an “outperform” rating on the stock in a research report on Monday, March 9th. Leerink Partners dropped their target price on shares of Ardent Health from $16.00 to $15.00 and set an “outperform” rating on the stock in a research report on Friday, March 6th. Wall Street Zen raised shares of Ardent Health from a “hold” rating to a “buy” rating in a research report on Saturday, May 16th. Zacks Research raised shares of Ardent Health from a “strong sell” rating to a “hold” rating in a research report on Wednesday, March 25th. Finally, UBS Group boosted their target price on shares of Ardent Health from $13.00 to $13.50 and gave the stock a “buy” rating in a research report on Thursday, May 7th. Seven research analysts have rated the stock with a Buy rating, five have issued a Hold rating and two have assigned a Sell rating to the stock. According to data from MarketBeat.com, the stock presently has a consensus rating of “Hold” and an average target price of $14.21.
Ardent Health Trading Up 1.3%
Shares of Ardent Health stock opened at $9.41 on Thursday. The firm has a market capitalization of $1.35 billion, a PE ratio of 9.91, a price-to-earnings-growth ratio of 2.07 and a beta of 0.93. The company has a debt-to-equity ratio of 0.62, a current ratio of 2.12 and a quick ratio of 2.00. The company’s fifty day moving average price is $9.38 and its two-hundred day moving average price is $9.25. Ardent Health, Inc. has a 52-week low of $8.07 and a 52-week high of $15.48.
Ardent Health (NYSE:ARDT – Get Free Report) last announced its quarterly earnings results on Tuesday, May 5th. The company reported $0.28 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.18 by $0.10. The firm had revenue of $1.60 billion for the quarter, compared to analyst estimates of $1.58 billion. Ardent Health had a net margin of 2.09% and a return on equity of 13.85%. Ardent Health has set its FY 2026 guidance at 0.900-1.270 EPS. On average, analysts expect that Ardent Health, Inc. will post 1.12 EPS for the current year.
About Ardent Health
Ardent Health, listed on the New York Stock Exchange under the ticker ARDT, is a healthcare delivery company focused on acquiring, developing and managing acute care hospitals and complementary outpatient facilities across the United States. The company’s integrated platform encompasses both inpatient and outpatient services, designed to provide end-to-end care solutions and address the full continuum of patient needs.
Through its network, Ardent Health operates general hospitals, emergency departments, ambulatory surgery centers, urgent care clinics, rehabilitation and post-acute care facilities.
Featured Articles
- Five stocks we like better than Ardent Health
- Abercrombie Rallies as Strong Q1 Earnings Extend Winning Streak
- TeraWulf Bets on Power Infrastructure to Lead AI Build-Out
- Amazon’s Alexa for Shopping Strengthens an Already Strong Bull Case
- Keysight: The AI and Defense Stock Seeing Big Price Target Boosts
Want to see what other hedge funds are holding ARDT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Ardent Health, Inc. (NYSE:ARDT – Free Report).
Receive News & Ratings for Ardent Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ardent Health and related companies with MarketBeat.com's FREE daily email newsletter.
